Expert: With New COVID-19 Vaccine Approvals, Pharmacists Should Remain Vigilant
Allison Hill, PharmD, RPh, emphasized that pharmacists must stay updated on ACIP and state-level guidance following HHS’s changes to COVID-19…
New Nanoparticle Treatment Shows Promise for Preventing Rheumatoid Arthritis Flares
An immunomodulatory nanoparticle called Agg-CLNP has been shown to effectively prevent disease onset for rheumatoid arthritis (RA).
Pneumococcal Positivity Associated With More Severe COVID-19 Outcomes
Patients with severe COVID-19 who tested positive for Streptococcus pneumoniae had higher mortality rates.
FDA Approves REMS Modification for Sparsentan in IgA Nephropathy
The FDA updated sparsentan’s REMS, easing monitoring requirements, enhancing treatment access for IgA nephropathy patients, and supporting kidney function preservation.
FDA Approves Generic Version of Liraglutide Injection, a GLP-1 for Weight Loss
Generic liraglutide injection is the first GLP-1 indicated for weight loss.
Switching From Reference Adalimumab to Biosimilar Shows No Major Differences in Patients With RA, PsA
Biosimilars can be a more affordable and accessible treatment option for patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).
Optimizing Patient Treatment Adherence in CML
A panelist discusses how pharmacists can significantly improve treatment adherence in chronic myeloid leukemia patients through regular patient touchpoints, adherence…
Guidelines vs. Real Life in mCRC: Success Isn’t ‘One Size Fits All’
Panelists discuss how endpoint prioritization in late-line metastatic colorectal cancer therapy differs between providers and patients, with pharmacists focusing primarily…
1056: Rapid administration of antiseizure medications
Show notes at pharmacyjoe.com/episode1056. In this episode, I’ll discuss the rapid administration of antiseizure medications. The post 1056: Rapid administration…